Topic Review
Psychosocial Interventions for Dyslexic Adults
       Enabling dyslexic adults’ participation in the work environment is vital to unleashing their potential and essential to make the workplace more inclusive. This can be supported through psychosocial interventions that target a set of positive self-evaluations commonly linked to resiliency and an individual’s sense of ability to control and impact the environment in a successful manner, including coping strategies and self-management. A systematic review has been carried out to map and integrate the understanding of interventions in this field. It reveals that interventions can be useful in enhancing psychological resources among dyslexic adults. Still, it also highlights the critical gap in this literature, where knowledge in this field remains mostly based on common sense rather than on evidence from research. Given the high incidence of dyslexia, its health consequences and high financial costs, this is particularly problematic and emphasizes the need for research designs to evaluate interventions’ effectiveness on the improvement of psychological resources and employment opportunities. More intervention studies are needed to understand the effects of initiatives on dyslexic adults’ psychological resources and well-being, employing validated and reliable scales for outcome assessment.
  • 928
  • 12 Oct 2020
Topic Review
TCR Therapy of Cancer
A thorough overview of principles, recent technological breakthroughs, and current status of TCR gene therapy for cancer.
  • 928
  • 09 Apr 2021
Topic Review
Anti-Inflammatory Agents in Prostate Cancer
Chronic inflammation is a major cause of human cancers. The environmental factors, such as microbiome, dietary components, and obesity, provoke chronic inflammation in the prostate, which promotes cancer development and progression. Crosstalk between immune cells and cancer cells enhances the secretion of intercellular signaling molecules, such as cytokines and chemokines, thereby orchestrating the generation of inflammatory microenvironment. Tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) play pivotal roles in inflammation-associated cancer by inhibiting effective anti-tumor immunity. Anti-inflammatory agents, such as aspirin, metformin, and statins, have potential application in chemoprevention of prostate cancer. Furthermore, pro-inflammatory immunity-targeted therapies may provide novel strategies to treat patients with cancer. Thus, anti-inflammatory agents are expected to suppress the “vicious cycle” created by immune and cancer cells and inhibit cancer progression. This review has explored the immune cells that facilitate prostate cancer development and progression, with particular focus on the application of anti-inflammatory agents for both chemoprevention and therapeutic approach in prostate cancer.
  • 928
  • 30 Apr 2021
Topic Review
Patient-Controlled Analgesia
Patient-controlled analgesia (PCA) is an effective method for controlling acute pain, including postoperative pain in adults and in children from five years of age, pain resulting from labor, trauma, or other medical situations, or chronic and malignant pain. The treatment consists of a mini-computer-controlled infusion pump permitting the administration of on-demand, continuous, or combined doses of analgesic (mainly opioid) variations in response to therapy, which allows pain to be significantly controlled. Intravenous (IV)-PCA minimizes individual pharmacodynamics and pharmacokinetic differences and is widely accepted as a reference method for mild or severe postoperative pain. IV-PCA is the most studied route of PCA; other delivery methods have been extensively reported in the literature. In addition, IV-PCA usually voids the gap between pain sensation and analgesic administration, permitting better recovery and fewer side effects. The most commonly observed complications are nausea and vomiting, pruritus, respiratory depression, sedation, confusion and urinary retention. However, human factors such as pharmacy preparation and device programming can also be involved in the occurrence of these complications, while device failure is much less of an issue. 
  • 927
  • 10 Mar 2022
Topic Review
PTEN in different TME compartments
Mounting preclinical and clinical evidence indicates that rewiring the host immune system in favor of an antitumor microenvironment achieves remarkable clinical efficacy in the treatment of many hematological and solid cancer patients. Nevertheless, despite the promising development of many new and interesting therapeutic strategies, many of these still fail from a clinical point of view, probably due to the lack of prognostic and predictive biomarkers. In that respect, several data shed new light on the role of the tumor suppressor phosphatase and tensin homolog on chromosome 10 (PTEN) in affecting the composition and function of the tumor microenvironment (TME) as well as resistance/sensitivity to immunotherapy. In this review, we summarize current knowledge on PTEN functions in different TME compartments (immune and stromal cells) and how they can modulate sensitivity/resistance to different immunological manipulations and ultimately influence clinical response to cancer immunotherapy
  • 927
  • 04 Aug 2020
Topic Review
COPD T-cells and Comorbidity Biomarkers
In smoking-induced chronic obstructive pulmonary disease (COPD), various comorbidities are linked to systemic inflammation and infection-induced exacerbations. The underlying mechanisms are unclear but might provide therapeutic targets. T-cell activity is central in systemic inflammation and for infection-defense mechanisms and might be influenced by comorbidities. Hypothesis: Circulating biomarkers of comorbidities modulate the activity of T-cells of the T-helper type 1 (Th1) and/or T-cytotoxic type 1 (Tc1). T-cells in peripheral blood mononuclear cells (PBMCs) from non-smokers (NS), current smokers without COPD (S), and COPD subjects (total n = 34) were ex vivo activated towards Th1/Tc1 and were then stimulated with biomarkers for metabolic and/or cardiovascular comorbidities (Brain Natriuretic Peptide, BNP; chemokine (C-C motif) ligand 18, CCL18; C-X3-C motif chemokine ligand 1, CX3CL1; interleukin-18, IL-18) or for asthma- and/or cancer-related comorbidities (CCL22; epidermal growth factor, EGF; IL-17; periostin) each at 10 or 50 ng/mL. The Th1/Tc1 activation markers interferon-γ (IFNγ), tumor necrosis factor-α (TNFα), and granulocyte-macrophage colony-stimulating factor (GM-CSF) were analyzed in culture supernatants by Enzyme-Linked Immunosorbent Assay (ELISA). Ex-vivo activation induced IFNγ and TNFα without differences between the groups but GM-CSF more in S vs. NS. At 10 ng/mL, the different biomarkers increased or reduced the T-cell activation markers without a clear trend for one direction in the different categories of comorbidities or for the different T-cell activation markers. At 50 ng/mL, there was a clear shift towards suppressive effects, particularly for the asthma— and cancer-related biomarkers and in cells of S and COPD. Comorbidities might suppress T-cell immunity in COPD. This could explain the association of comorbidities with frequent exacerbations.
  • 927
  • 14 Jul 2021
Topic Review
Premature Ovarian Insufficiency and Infertility
Reproductive aging is on the rise globally and inseparable from the entire aging process. An extreme form of reproductive aging is premature ovarian insufficiency (POI), which to date has mostly been of idiopathic etiology, thus hampering further clinical applications and associated with enormous socioeconomic and personal costs. In the field of reproduction, timely diagnosis with a clear understanding of the various comorbidities that can arise from estrogen deficiency and the important functional role of inflammation-induced ovarian deterioration are research hotspots for appropriate counseling and preventing this prematurely ovarian aging disease. It is evident that more research is required to allow pre-emptive identification of the at-risk population and to identify mechanisms that, if addressed promptly, can prolong ovarian function and fertility.
  • 926
  • 30 Dec 2022
Topic Review
Oxygen, pH, Lactate, and Metabolism for Wound Treatment
Over time, we have come to recognize a very complex network of physiological changes enabling wound healing. An immunological process allows the body to distinguish damaged cells and begin a cleaning mechanism by separating damaged proteins and cells with matrix metalloproteinases, a complement reaction, and free radicals. A wide variety of cell functions help to rebuild new tissue, dependent on energy provision and oxygen supply. Topically applied lactate can improve this.
  • 926
  • 12 Nov 2021
Topic Review
Nanoplastic and the Gut-Brain Axis
The widespread usage of plastic places a significant burden on the environment and impacts numerous aquatic and terrestrial species. Humans in particular can be affected by plastic pollution, predominantly via inhalation and ingestion, as well as trophic transfer along the food chain. Under natural conditions synthetic materials undergo degradation into micro- and nanoparticles, especially prone to interact with biological systems. Organisms exposed to nanoplastic accumulate it in multiple tissues, including the gut and the brain. The scarce but consistent evidence shows that exposure to plastic nanoparticles can indeed affect both the digestive and the nervous system, therefore, potentially pose a threat to the complex network of mutual interactions between them, known as the gut-brain axis.
  • 926
  • 28 Mar 2022
Topic Review
Fusarium Cyclodepsipeptide Mycotoxins
Most of the fungi from the Fusarium genus are pathogenic to cereals, vegetables, and fruits, and the products of their secondary metabolism mycotoxins may accumulate in foods and feeds. Non-ribosomal cyclodepsipeptides are one of the main mycotoxin groups and include beauvericins (BEAs), enniatins (ENNs), and beauvenniatins (BEAEs).
  • 926
  • 08 Feb 2021
  • Page
  • of
  • 1352
ScholarVision Creations